Imperial College London
Alternate

DrJonathanBaker

Faculty of Medicine, National Heart & Lung Institute

Honorary Senior Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7594 7790jonathan.baker

 
 
//

Location

 

223Guy Scadding BuildingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Ramakrishnan:2021:10.1016/S2213-2600(21)00160-0,
author = {Ramakrishnan, S and Nicolau, D and Langford, B and Mahdi, M and Jeffers, H and Mwasuku, C and Krassowska, K and Fox, R and Binnian, I and Glover, V and Bright, S and Butler, C and Cane, J and Halner, A and Matthews, P and Donnelly, L and Simpson, J and Baker, J and Fadai, N and Peterson, S and Bengtsson, T and Barnes, P and Russell, R and Bafadhel, M},
doi = {10.1016/S2213-2600(21)00160-0},
journal = {LANCET RESPIRATORY MEDICINE},
pages = {763--772},
title = {Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial},
url = {http://dx.doi.org/10.1016/S2213-2600(21)00160-0},
volume = {9},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Ramakrishnan,S
AU  - Nicolau,D
AU  - Langford,B
AU  - Mahdi,M
AU  - Jeffers,H
AU  - Mwasuku,C
AU  - Krassowska,K
AU  - Fox,R
AU  - Binnian,I
AU  - Glover,V
AU  - Bright,S
AU  - Butler,C
AU  - Cane,J
AU  - Halner,A
AU  - Matthews,P
AU  - Donnelly,L
AU  - Simpson,J
AU  - Baker,J
AU  - Fadai,N
AU  - Peterson,S
AU  - Bengtsson,T
AU  - Barnes,P
AU  - Russell,R
AU  - Bafadhel,M
DO  - 10.1016/S2213-2600(21)00160-0
EP  - 772
PY  - 2021///
SN  - 2213-2600
SP  - 763
TI  - Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
T2  - LANCET RESPIRATORY MEDICINE
UR  - http://dx.doi.org/10.1016/S2213-2600(21)00160-0
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000668591900029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 9
ER  -
Download